FDA

News and Updates by the Food and Drugs Administration (FDA)

Specialist Sheds Light on the Vital Importance of X-ray and PFT Devices in Enhancing COPD Diagnosis

With a growing awareness around respiratory health issues, medical professionals emphasize the importance of early detection and lifestyle adjustments for those affected by chronic obstructive pulmonary disease (COPD). Dr. Ujjwal Parakh, a leading consultant in chest medicine at Sir Ganga […]

Specialist Sheds Light on the Vital Importance of X-ray and PFT Devices in Enhancing COPD Diagnosis Read More »

LAPIX Therapeutics Reveals Encouraging Phase 1 Trial Outcomes for Autoimmune Therapy LPX-TI641

**Encouraging News from LAPIX Therapeutics** LAPIX Therapeutics, Inc., a company specializing in innovative oral treatments aimed at restoring immune system balance in autoimmune disorders, has announced promising initial findings from their phase 1 trial. This study was a randomized, double-blind,

LAPIX Therapeutics Reveals Encouraging Phase 1 Trial Outcomes for Autoimmune Therapy LPX-TI641 Read More »

Alloy Therapeutics Partners with Takeda to Advance Cell Therapy Framework

Alloy Therapeutics Inc., a biotechnology company committed to making advanced drug discovery technologies more accessible, has entered into a strategic partnership and license agreement with Takeda Pharmaceutical Company Limited. This collaboration aims to enhance Takeda’s advanced iPSC-derived CAR-T cell platform

Alloy Therapeutics Partners with Takeda to Advance Cell Therapy Framework Read More »

Urban Genomic Research Links Genetic Profiling to Increased Survival Rates

**Headline:** Urban Genomic Research Links Genetic Profiling to Increased Survival Rates **Content:** Over a span of seven years (2015-2021), Metropolis Healthcare embarked on a pivotal research endeavor to investigate the clinicopathological characteristics and molecular transformations in patients with lung cancer.

Urban Genomic Research Links Genetic Profiling to Increased Survival Rates Read More »

Sahyadri Hospitals Achieves Breakthrough in Safely Removing Rare Brain Tumour from 57-Year-Old using Cutting-Edge Neurosurgical Techniques

A 57-year-old woman, experiencing intense headaches and mobility issues, has made a substantial recovery after a sophisticated neurosurgical procedure at Sahyadri Super Speciality Hospital, Hadapsar. Having previously consulted several hospitals in the vicinity, she was eventually identified with multiple meningiomas

Sahyadri Hospitals Achieves Breakthrough in Safely Removing Rare Brain Tumour from 57-Year-Old using Cutting-Edge Neurosurgical Techniques Read More »

LoEstro Advisors and Medium Healthcare Report Foresees Indian Healthcare Challenges

A recent study by LoEstro Advisors in cooperation with leading healthcare consultant Medium Healthcare, titled “Hospitals for Bharat,” has highlighted significant challenges alongside potential opportunities within India’s healthcare delivery. The report sheds light on the troubling situation: while small and

LoEstro Advisors and Medium Healthcare Report Foresees Indian Healthcare Challenges Read More »

European Medicines Agency Awards PRIME Designation to NZ-5948 for Treating Certain Cancers

Nurix Therapeutics, a clinical-stage company known for developing drugs that adjust protein levels to target cancer and inflammatory diseases, has announced a significant milestone. The European Medicines Agency (EMA) has designated its drug, NX-5948, for PRIME (PRIority MEdicines) status. This

European Medicines Agency Awards PRIME Designation to NZ-5948 for Treating Certain Cancers Read More »